SCHEMBL432225

SCHEMBL432225

CC(=O)/C=C/c1ccc(Cl)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.69
GLA P06280 1/20 0.63
TDP1 Q9NUW8 1/20 0.63
MAOB P27338 7/20 0.58
MAOA P21397 3/20 0.58
NPC1 O15118 1/20 0.58
ALDH1A1 P00352 1/20 0.58
LMNA P02545 1/20 0.58
MAPT P10636 1/20 0.58
HTT P42858 1/20 0.58
RAB9A P51151 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
HDAC2 Q92769 3/20 0.56
IAPP P10997 1/20 0.55
PTGS1 P23219 1/20 0.55
CXCL12 P48061 1/20 0.55
HDAC3 O15379 2/20 0.53
HDAC4 P56524 2/20 0.53
HDAC1 Q13547 2/20 0.53
HDAC7 Q8WUI4 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL432226 1.00 CYP1A2 (0.69) CYP1A2GLATDP1MAOBMAOA
SCHEMBL1359336 0.89 GLA (0.77) CYP1A2GLATDP1MAOBALDH1A1
SCHEMBL1359335 0.89 GLA (0.77) CYP1A2GLATDP1MAOBALDH1A1
SCHEMBL5020782 0.86 HDAC1 (0.72) CYP1A2NPC1ALDH1A1LMNAMAPT
SCHEMBL13843800 0.86 HDAC2 (0.66) CYP1A2GLATDP1MAOBMAOA
SCHEMBL5598994 0.82 CYP1A2 (1.00) CYP1A2MAOBMAOANPC1ALDH1A1
SCHEMBL28347012 0.82 CYP1A2 (0.75) CYP1A2MAOBMAOANPC1ALDH1A1
SCHEMBL5598991 0.82 CYP1A2 (1.00) CYP1A2MAOBMAOANPC1ALDH1A1
Methyl Alcohol SCHEMBL27319502 0.81 CYP1A2 (0.67) CYP1A2MAOBMAOANPC1ALDH1A1
SCHEMBL126171 0.80 CYP1A2 (0.72) CYP1A2GLATDP1MAOBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113620901-B Crown ether derived chiral 1,1 '-bi-2, 2' -naphthol, preparation method and application thereof 杭州师范大学 2023-02-10 CN claimed
CN-113620901-A Crown ether derived chiral 1,1 '-bi-2, 2' -naphthol, preparation method and application thereof 杭州师范大学 2021-11-09 CN claimed
CN-122038326-A Perakine reductase mutant and application thereof in double bond reduction 浙江大学 2026-05-15 CN disclosed
EP-4727923-A1 TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA University of Georgia Research Foundation, Inc. (US) 2026-04-22 EP disclosed
US-20260098012-A1 TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA UNIV GEORGIA (US) 2026-04-09 US disclosed
WO-2024258904-A1 TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2024-12-19 WO disclosed
CN-119120338-A Prostaglandin reductase and glucose dehydrogenase co-expression recombinant bacterium and application thereof 淮阴工学院 2024-12-13 CN disclosed
US-20230301984-A1 CYCLIC COMPOUNDS FOR USE IN TREATING RETINAL DEGENERATION THE USA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2023-09-28 US disclosed
US-20230301984-A1 CYCLIC COMPOUNDS FOR USE IN TREATING RETINAL DEGENERATION THE USA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2023-09-28 US disclosed
EP-3558962-B1 NITRONE HERBICIDES FMC CORP (US) 2023-07-12 EP disclosed
CN-110312712-B Nitrone herbicide FMC公司 2023-06-23 CN disclosed
US-4471129-A ANTIHISTAMINES LILLY INDUSTRIES LIMITED (GB) 1984-09-11 US disclosed
US-4448787-A ANTIALLERGENS LILLY INDUSTRIES LIMITED (GB) 1984-05-15 US disclosed
US-4400380-A HERBES VIRUS; TOPICAL MERRELL DOW PHARMACEUTICALS INC. (US) 1983-08-23 US disclosed
EP-0043141-A1 Pharmaceutical compositions having antiviral activity for topical administration and the use of 1-(substituted phenyl)-5-(4-morpholinyl)-1-penten-3-one compounds for the preparation of pharmaceutical compositions having an antiviral effect MERRELL DOW PHARMACEUTICALS INC. (US) 1982-01-06 EP disclosed
US-4304728-A 2,6-DIHYDROXY-2,5-HEXADIENOIC ACID DERIVATIVES, ANTIHISTAMINE INTERMEDIATES LILLY INDUSTRIES LIMITED (GB) 1981-12-08 US disclosed
US-4261988-A ANTICHOLESTEROL AGENTS USED IN ANIMAL HUSBANDRY BAYER AKTIENGESELLSCHAFT (DE) 1981-04-14 US disclosed
US-4113669-A Polymers flameproofed with 1,2-oxaphospholanes CIBA-GEIGY CORPORATION (US) 1978-09-12 US disclosed
US-4045518-A FLAMEPROOFING AGENTS CIBA-GEIGY CORPORATION (US) 1977-08-30 US disclosed
US-3989708-A HYPOTENSIVE, CORONARY VESSEL DILATORS BAYER AKTIENGESELLSCHAFT (DT) 1976-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260098012-A1 TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA CD47, SLC11A2, G6PD CYP1A2 1169/4885GLA 4412/4885TDP1 4043/4885
US-20230301984-A1 CYCLIC COMPOUNDS FOR USE IN TREATING RETINAL DEGENERATION ALDH1A2, PDE6D, PDE6C CYP1A2 3911/4885GLA 233/4885TDP1 65/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.